Mencarini, J., et al. “Risk of Cytomegalovirus Reactivation in Patients With Immune-Mediated Inflammatory Diseases Undergoing Biologic Treatment: A Real Matter?”. Reumatismo, vol. 68, no. 3, Dec. 2016, pp. 144-7, doi:10.4081/reumatismo.2016.897.